CTNI-72. PHASE 2 STUDY OF DIANHYDROGALACTITOL (VAL-083) IN PATIENTS WITH MGMT-UNMETHYLATED, BEVACIZUMAB-NAÏVE GLIOBLASTOMA IN THE RECURRENT AND ADJUVANT SETTING

Current standard-of-care for glioblastoma (GBM) includes surgery followed by concurrent therapy with radiation and temozolomide (TMZ) followed by adjuvant TMZ. Almost all GBM patients experience recurrent/progressive disease despite upfront standard of care treatment, with a median survival after re...

詳細記述

保存先:
書誌詳細
出版年:Neuro Oncol
主要な著者: O’Brien, Barbara, Penas-Prado, Marta, Kamiya-Matsuoka, Carlos, Weathers, Shiao-Pei, Yung, W K Alfred, Loghin, Monica, Harrison, Rebecca, Majd, Nazanin, Bacha, Jeffrey, Brown, Dennis, Johnson, Greg, Langlands, John, Schwartz, Richard, Kanekal, Sarath, Steino, Anne, Lopez, Lorena, de Groot, John
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2020
主題:
Clinical Trials: Non-Immunologic
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651480/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.238
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料